On April 8, 2024, Seres Therapeutics, Inc announced that it has held its annual general meeting of shareholders on April 4, 2024, and declared voting results. Accordingly, a stockholder proposal on simple majority vote from Kenneth Steiner was approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.812 USD | +15.70% | +12.19% | -42.00% |
Jun. 24 | Omega Therapeutics, Inc. Appoints Richard N. Kender to Board of Directors | CI |
Jun. 11 | Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.00% | 123M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Declaration of Voting Results by Seres Therapeutics